Table 3.
Summary of carbon-based scaffolds for bone tissue engineering.
| Scaffold composition | Cells (in vitro) | Key findings | Ref. |
|---|---|---|---|
| CNF compacts & PLGA casts of nanophase carbon fibers | Human osteoblasts |
|
[158] |
| Electrospun ECNFs/HA | MG-63 |
|
[33] |
| Electro-conductive electrospun CNFs-medicated DCF | MG-63 |
|
[147] |
| ECNFs/SNPs | MG-63 |
|
[143] |
| Electro-conductive electrospun CNFs/Fe2O3 | MG-63 |
|
[133] |
| Electro-conductive ECNFs/AuNP | MG-63 |
|
[159] |
| Electrospun β-TCP/ECNFs membranes | PDLCs |
|
[160] |
| Electrospun β-TCP@ECNFs membranes | MG-63 |
|
[161] |
| Thermal-based electrospun ECNF/BG | MC3T3-E1 |
|
[162] |
| Sol-gel based Electrospun CNF/BG | MC3T3-E1 |
|
[152] |
| Electrospun CNF/BG | Rat BM-MSCs |
|
[163] |
| BC nanofibers-derived 3-D CNF/HAp | – |
|
[156] |
| Electrospun ECNF/HAp | – |
|
[164] |
| Sol-gel based ECNF-Si/Ca | Normal human skin fibroblastsNHOst |
|
[165] |
| PP/CNF-HANR | Saos-2 |
|
[166] |
Abbreviations: PLGA: poly(lactic-co-glycolic acid; HA/HAp: Hydroxyapatite; DCF: Direct current field; SNPs: Silica nanoparticles; Fe2O3: Ferrous sulfate; AuNP: Gold nanoparticle; β-TCP: β-tricalcium phosphate; BG: Bioglass; BC: Bacterial cellulose; ECNF-Si/Ca: Electrospun CNF-silica/calcium; PP/CNF–HANR: Polypropylene/carbon nanofiber-hydroxyapatite nanorod; PLA: poly(lactic acid); PCL: poly-ε-caprolactone; g-C3N4: Graphitic carbon nitride; MWCNTs: Multiwalled carbon nanotubes; f-MWCNT/Chitosan/B-GP: Functionalized multiwalled carbon nanotubes/chitosan/β-Glycerophosphate; MG-63: Human osteoblastic cell line; PDLCs: Human periodontal ligament cells; MC3T3-E1: Mouse osteoblastic cell line; BM-MSCs: Bone marrow-derived primary MSCs; NHOst: Normal human osteoblasts; Saos-2: Human osteoblast cell line; HNO3: Nitric acid; ALP: Alkaline phosphatase.